Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LASIK-KLINIKKEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   4.6% 6.2% 12.7% 15.8% 15.8% 17.9% 20.3% 15.6%   Credit score (0-100)   49 40 20 13 12 7 5 11   Credit rating   BBB BBB BB BB BB B B BB   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,296 443 -20.9 -240 -84.2 -24.0 0.0 0.0   EBITDA   1,033 -46.9 -307 -544 -345 -24.0 0.0 0.0   EBIT   1,010 -71.7 -331 -591 -345 -24.0 0.0 0.0   Pre-tax profit (PTP)   1,000.7 -38.5 -341.9 -615.2 -345.1 -27.2 0.0 0.0   Net earnings   779.4 -39.4 -331.9 -608.5 -209.6 -27.2 0.0 0.0   Pre-tax profit without non-rec. items   1,001 -38.5 -342 -615 -345 -27.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   176 151 127 79.8 0.0 0.0 0.0 0.0   Shareholders equity total   980 158 -174 -782 -992 -1,019 -1,144 -1,144   Interest-bearing liabilities   33.6 233 345 943 1,004 1,022 1,144 1,144   Balance sheet total (assets)   1,302 481 298 229 58.5 3.7 0.0 0.0   Net Debt   -261 -50.1 234 805 945 1,018 1,144 1,144     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,296 443 -20.9 -240 -84.2 -24.0 0.0 0.0   Gross profit growth   0.0% -65.8% 0.0% -1,046.7% 64.9% 71.5% 0.0% 0.0%   Employees   0 0 1 1 1 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,302 481 298 229 59 4 0 0   Balance sheet change%   0.0% -63.0% -38.1% -23.3% -74.4% -93.6% -100.0% 0.0%   Added value   1,032.7 -46.9 -306.6 -544.3 -298.2 -24.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   153 -49 -49 -93 -80 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 -4.0 -5.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   78.0% -16.2% 1,581.9% 246.1% 409.8% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   78.8% -4.3% -69.5% -79.7% -33.5% -2.3% 0.0% 0.0%   ROI %   99.9% -5.4% -86.7% -90.3% -35.3% -2.4% 0.0% 0.0%   ROE %   79.6% -6.9% -145.5% -231.1% -146.0% -87.5% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   75.2% 32.9% -36.8% -77.4% -94.4% -99.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -25.2% 106.7% -76.2% -147.9% -274.0% -4,239.2% 0.0% 0.0%   Gearing %   3.4% 147.4% -198.8% -120.6% -101.2% -100.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   151.7% 0.0% 3.7% 3.8% 0.0% 0.3% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   3.5 1.0 0.3 0.1 0.1 0.0 0.0 0.0   Current Ratio   3.5 1.0 0.3 0.1 0.1 0.0 0.0 0.0   Cash and cash equivalent   294.2 283.3 111.5 137.9 58.5 3.7 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   783.6 -12.2 -320.0 -854.9 -991.7 -1,018.9 -572.0 -572.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -307 -544 -298 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -307 -544 -345 0 0 0   EBIT / employee   0 0 -331 -591 -345 0 0 0   Net earnings / employee   0 0 -332 -608 -210 0 0 0